Revelation Biosciences Stock Quote REVB - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.74

Bid

0.6901

Ask

0.7989

Volume

0.00 Day's Range 0.00

0.702 52 Week Range 25.26

Market Cap

1.216M

Previous Close

0.74

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,775,436

Shares Outstanding

1,643,395

Dividend Yield

PE Ratio

-0.27

Earnings Per Share (EPS)

-0.07

Revenue

Net Profit

-120k

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to ... Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Headquarters

Lewes, Delaware, USA

Founded

2022

Revelation Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker REVB. The last closing price for Revelation Biosciences was $0.74. Over the last year, Revelation Biosciences shares have traded in a share price range of $ 0.702 to $ 25.26.

Revelation Biosciences currently has 1,643,395 shares outstanding. The market capitalization of Revelation Biosciences is $1.22 million. Revelation Biosciences has a price to earnings ratio (PE ratio) of -0.27.

FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.179	-19.4776931447	0.919	0.9637	0.702	485071	0.79496396	CS
4	-0.44	-37.2881355932	1.18	1.2	0.702	290327	0.9003969	CS
12	-1.05	-58.6592178771	1.79	3.5	0.702	1775436	1.94535817	CS
26	-1.65	-69.0376569038	2.39	3.8	0.702	1120807	2.06500904	CS
52	-20.392	-96.4982017793	21.132	25.26	0.702	699000	3.30062721	CS
156	-8798.26	-99.9915899534	8799	10237.5	0.702	1291911	825.47137741	CS
260	-8798.26	-99.9915899534	8799	10237.5	0.702	1291911	825.47137741	CS

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	$ 11.04 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1458 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.95 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.89 (0.00%)	0
AACGATA Creativity Global	$ 0.6796 (0.00%)	0
AALAmerican Airlines Group Inc	$ 11.04 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1458 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.95 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.89 (0.00%)	0
AACGATA Creativity Global	$ 0.6796 (0.00%)	0
AALAmerican Airlines Group Inc	$ 11.04 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1458 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.95 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.89 (0.00%)	0
AACGATA Creativity Global	$ 0.6796 (0.00%)	0

Symbol

Price

Vol.